×

Quality control procedure for membrane flow-through diagnostic assay devices

  • US 6,057,165 A
  • Filed: 02/07/1997
  • Issued: 05/02/2000
  • Est. Priority Date: 02/07/1997
  • Status: Expired due to Fees
First Claim
Patent Images

1. A method for determining the presence of an analyte in a fluid sample, said method employing an assay test kit including an assay device having a porous membrane having an upper surface and a lower surface, a test area on the upper surface of said membrane, a binder for the analyte attached to said test area, a flow control layer having an upper and lower surface wherein the upper surface of the flow control layer is adjacent to the lower surface of the porous membrane, a porous spacer layer having an upper and lower surface wherein the upper surface of the porous spacer layer is adjacent to the lower surface of the flow control layer, and an absorptive layer having an upper and lower surface wherein the upper surface of the absorptive layer is adjacent to the lower surface of the porous spacer layer;

  • a delivery device comprising a well for receiving the fluid sample, said well having an opening at a lower end thereof, wherein said fluid sample is capable of being delivered through the well to a portion of the test area on the upper surface of said porous membrane of the assay device;

    a vessel containing a tracer having a tag, wherein said tracer is for application to said portion of the test area whereby the tag of said tracer is detected in said portion of the test area when the analyte is present in the fluid sample; and

    a vessel containing an analyte positive control sample comprising said analyte which is applied to the test area and said tracer is applied to the test area whereby the tag of said tracer is detected in said test area thus confirming that said analyte is specifically bound by said binder in the test area;

    said method comprising;

    (a) running the assay device by;

    (i) contacting the portion of the test area of the assay device using the delivery device with the fluid sample and the tracer having a tag that is visible when bound at the portion of the test area under assay conditions such that any analyte and tracer not specifically bound at the portion of the test area flows through the test area;

    (ii) removing the delivery device and determining visibility of the tag of the tracer specifically bound at the portion of the test area as a measure of analyte present in the fluid sample;

    (b) re-running the assay device by;

    (i) contacting the test area of the assay device with the analyte positive control sample and the tracer having a tag that is visible when bound at the test area under assay conditions such that any analyte and tracer not specifically bound at the test area flows through the test area; and

    (ii) determining visibility of the tag of the tracer specifically bound at the test area as an indication that said analyte is specifically bound by said binder in the test area of the assay device.

View all claims
  • 1 Assignment
Timeline View
Assignment View
    ×
    ×